TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,927,000 | -14.9% | 119,324 | 0.0% | 0.26% | -15.8% |
| Q2 2021 | $9,310,000 | -17.5% | 119,324 | 0.0% | 0.30% | -21.9% |
| Q1 2021 | $11,287,000 | -22.4% | 119,324 | 0.0% | 0.39% | -24.1% |
| Q4 2020 | $14,540,000 | +2831.5% | 119,324 | +2001.9% | 0.51% | +2589.5% |
| Q3 2020 | $496,000 | +35.1% | 5,677 | 0.0% | 0.02% | +35.7% |
| Q2 2020 | $367,000 | +44.5% | 5,677 | 0.0% | 0.01% | +27.3% |
| Q1 2020 | $254,000 | -28.2% | 5,677 | 0.0% | 0.01% | -15.4% |
| Q4 2019 | $354,000 | – | 5,677 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |